The FNTB-609G>C polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e16534-e16534
Author(s):  
Pauline Wimberger ◽  
Hagen Sjard Bachmann ◽  
Andreas Du Bois ◽  
Rainer Kimmig ◽  
Jan Dominik Kuhlmann ◽  
...  
2014 ◽  
Vol 73 (4) ◽  
pp. 857-867 ◽  
Author(s):  
Daniel E. Castellano ◽  
Joaquim Bellmunt ◽  
José Pablo Maroto ◽  
Albert Font-Pous ◽  
Rafael Morales-Barrera ◽  
...  

2002 ◽  
Vol 21 (12) ◽  
pp. 1711-1726 ◽  
Author(s):  
Seth M. Steinberg ◽  
David J. Venzon

Oncotarget ◽  
2017 ◽  
Vol 8 (51) ◽  
pp. 88376-88385
Author(s):  
Dung-Tsa Chen ◽  
Po-Yu Huang ◽  
Hui-Yi Lin ◽  
Alberto A. Chiappori ◽  
Dmitry I. Gabrilovich ◽  
...  

Author(s):  
Jason R Brown ◽  
Daniel K. Chan ◽  
Jessica J Shank ◽  
Kent A. Griffith ◽  
Huihui Fan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document